Feed/Investors/Ligand Pharmaceuticals

Ligand Pharmaceuticals

The rounds this investor is named on, who it invests beside, and where it shows up.

Named on one round in the feed.

Since 2026-09-24

ROUNDS

joined, none as lead

ROUNDS JOINED · USD

$6M

across 1 round

LATEST ROUND

Series C · $6M · 2026-09-24

TOP SECTOR

Biotech

1 of 1 round

Rounds

[ 1 ]

The rounds this investor is named on, who it invests beside, and where it shows up.

Company	Round	Amount	Announced	Role
AvenCell Therapeutics A privately held clinical-stage company developing CAR-T therapies	Series C Verified against 3 sources	$6M	2026-09-24	[ PART ]

Ligand Pharmaceuticals: 1 round · Fireround